Groups
Company Size (Fulltime employees)
Partnering Objectives
Functionality
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Index
Countries
Reset

Mr. Keith Ignotz United States

Replace eye drops from FREEDOM drug releasing clear contact lens corneal bandage. The device has a 7 day wear time consistent with the standard of care recall after; cataract, LASIK surgery & corneal abrasion & non infectious Uveitis. Doctor puts device on and takes it off eliminating patient compliance problems with quicker healing with drug constantly treating the target tissue. 10 granted patents with FTO legal opinion. 10 mono and combo ophthalmic Dougs tested. Completed in vivo safety study. Letter and meeting being set with the US FDA for phase 1-2 clinical in January 2021.
Website:
www.OcuMedics.com
Company Size (Fulltime employees)
1-10
Year of foundation
2006
Partnering Objectives
Please specify your partnering goal
Investment regulatory CFDA, manufacturing & distribution
Headquartner in China
No
OcuMedic, Inc.
President & CEO 
Functionality
Management

Mr. Tony Ihander Monaco

Venture Capital and fundraising for fast growing companies. Action means action.
Website:
https://actionventures.eu/
Company Size (Fulltime employees)
1-10
Year of foundation
1991
Partnering Objectives
Please specify your partnering goal
To accelerate new companies with the capital.
Headquartner in China
No
Action Ventures
Founder 
Functionality
Investment